GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pacira BioSciences Inc (FRA:82P) » Definitions » 3-Year EPS without NRI Growth Rate

Pacira BioSciences (FRA:82P) 3-Year EPS without NRI Growth Rate : -32.20% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Pacira BioSciences 3-Year EPS without NRI Growth Rate?

Pacira BioSciences's EPS without NRI for the three months ended in Mar. 2024 was €0.20.

During the past 12 months, Pacira BioSciences's average EPS without NRI Growth Rate was 144.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was -32.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 93.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Pacira BioSciences was 348.10% per year. The lowest was -35.10% per year. And the median was 30.95% per year.


Competitive Comparison of Pacira BioSciences's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Pacira BioSciences's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacira BioSciences's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pacira BioSciences's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Pacira BioSciences's 3-Year EPS without NRI Growth Rate falls into.



Pacira BioSciences 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Pacira BioSciences  (FRA:82P) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Pacira BioSciences 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Pacira BioSciences's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacira BioSciences (FRA:82P) Business Description

Traded in Other Exchanges
Address
5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

Pacira BioSciences (FRA:82P) Headlines

No Headlines